NCT05756543Completed
Counterfactual Thinking and Decision-making in Parkinson's Disease
Counterfactual Thinking About Clinical Decision and Decision-making in the Context of the Parkinson's Disease.
Source: ClinicalTrials.gov · Last updated 26 Aug 2025
Brief summary (registry, in English)
The aim of this research is to verify the ability of counterfactual thinking about medical decisions in individuals affected by Parkinson's Disease when compared to healthy individuals.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 22 Feb 2023
- Start date
- 30 Mar 2022
- Primary completion date
- 30 Mar 2024
- Lead sponsor
- Istituto Auxologico Italiano
- Diseases
- Parkinson disease
- NCT number
- NCT05756543
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 30 Mar 2022 to the primary completion date, 30 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent neurological, neurodevelopmental (e.g., autism), motor, and/or psychiatric disorders;
Other illness
- Diagnosis of Obstructive Sleep Apnea Syndrome, according to the clinical assessment;
- Dementia, according to the clinical/neuropsychological assessment.
Who the study is looking for
- Diagnosis of Parkinson's disease, according to the medical assessment performed by trained neurologists.
Age in the registry: 20 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe Coordinator of this site? Confirm its status | Piancavallo | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.